Applying science to care.

Medavera identifies gaps in knowledge and care, methodically researches the subject matter, identifies the top experts to guide the content, and then utilizes a format that will provide the best learning opportunity. We are always looking for new teaching methods and technologies in order to offer stimulating and actionable medical education. Medical education must be meaningful to become applied to clinical practice. Great content, respected leaders, and interesting formats create successful interactions and learning.
FEATURED PROJECT

Pre-exposure Prophylaxis (PrEP):
Evolving Strategies for HIV Prevention, Treatment, and Testing
Thursday, March 30, 2017
1:00-2:00 pm ET

HIVEarlyTesting.com

This accredited educational webinar presented by Drs. Cynthia C. Brinson and David W. Rosenthal, will review the development and rationale behind pre-exposure prophylaxis (PrEP), identify potential barriers to HIV screening and initiation of PrEP, evaluate current CDC and HRSA guidelines for HIV testing/screening/analysis, determine the role of rapid point-of-care HIV antigen/antibody testing in prophylaxis and early treatment, and discuss strategies to increase screening, earlier interventions, and greater implementation of PrEP to prevent HIV infection.

There is no charge for the program or certificate, but registration is required for the webinar, access to the slides, and CME assessment.

Planned and developed by Medavera, Inc. and supported by Alere, Inc.

THE MEDICAL NEWS
WASHINGTON (Reuters) - U.S. House leaders have decided against holding a vote on a reworked healthcare system overhaul this week after failing to find the necessary support, congressional aides said on Thursday.... (Reuters Health) – Even as doctors are increasingly relying on home blood pressure monitoring to manage patients with hypertension, many of the devices are too inaccurate to be useful, according to a small study.... (Reuters Health) - U.S. public health officials declared victory over malaria in 1951, but the mosquito-borne disease continues to infect and kill American travelers, a new study shows.... (Reuters) - The U.S. Food and Drug Administration approved Novartis AG's Rydapt as an initial treatment for acute myeloid leukemia (AML) as well as certain other blood disorders, the agency said on Friday.... GENEVA (Reuters) - Eleven people have died and five are in hospital, Liberian officials said on Friday, after contracting a mystery illness the World Health Organisation (WHO) said was linked to attendance at the funeral of a religious leader.... NEW DELHI/MUMBAI (Reuters) - A group of global medical-technology companies plans to tell Indian officials next month that any further price control measures would risk future investments and make them less likely to introduce new products in the country, according to an industry source familiar with the matter. The lobbying effort by Abbott Laboratories, Boston Scientific, Johnson & Johnson and others comes after the government of Prime Minister Narendra Modi in February set a price cap for... (Reuters) - The U.S. Food and Drug Administration said on Thursday it has approved Bayer AG's drug Stivarga to treat liver cancer, the first such approval in nearly a decade.... SEOUL (Reuters) - South Korea said on Thursday it has fined Swiss drugmaker Novartis 55.1 billion won ($48.80 million) for offering doctors kickbacks to recommend the company's drugs, and also suspended insurance coverage for some of its drugs.... (Reuters Health) - Despite increased attention to deaths and injuries resulting from clashes with police, U.S. emergency department visits for police-associated injuries have remained stable at about 51,000 a year since 2006, researchers say.... LONDON (Reuters) - A special U.K. Cancer Drugs Fund (CDF) set up in 2010 spent over 1.2 billion pounds ($1.55 bln) but failed to deliver value for patients or society and may have caused unnecessary suffering, an analysis has found....